AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Rui Fang
Public Documents
1
June 06, 2025
Economic Evaluation of Toripalimab Plus Bevacizumab Versus Sorafenib as First-Line Th...
Rui Fang, feifeng sheng, tieqiao wang, et al.
